Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect
出版年份 2023 全文链接
标题
Can prophylactic HPV vaccination reduce the recurrence of cervical lesions after surgery? Review and prospect
作者
关键词
-
出版物
Infectious Agents and Cancer
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-29
DOI
10.1186/s13027-023-00547-2
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Effectiveness of Prophylactic Human Papillomavirus Vaccine in the Prevention of Recurrence in Women Conized for HSIL/CIN 2-3: The VENUS Study
- (2022) Andrea Casajuana-Pérez et al. Vaccines
- HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions
- (2022) Carla Henere et al. Vaccines
- Myths and fake messages about human papillomavirus (HPV) vaccination: answers from the ESGO Prevention Committee
- (2022) Nadja Taumberger et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- HPV vaccination introduction worldwide and WHO and UNICEF estimates of national HPV immunization coverage 2010–2019
- (2021) Laia Bruni et al. PREVENTIVE MEDICINE
- Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
- (2021) Arnaud John Kombe Kombe et al. Frontiers in Public Health
- Adjuvant HPV Vaccination to Prevent Recurrent Cervical Dysplasia after Surgical Treatment: A Meta-Analysis
- (2021) Violante Di Donato et al. Vaccines
- Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years
- (2021) Shujuan Lin et al. CANCER
- Human Papilloma Virus Vaccination
- (2021) Kendal Rosalik et al. Viruses-Basel
- If prophylactic HPV vaccination is considered in a woman with CIN2+, what is the value and should it be given before or after the surgical treatment?
- (2021) Wiebren A.A. Tjalma et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Rationale and design of a double-blind randomized non-inferiority clinical trial to evaluate one or two doses of vaccine against human papillomavirus including an epidemiologic survey to estimate vaccine efficacy: The Costa Rica ESCUDDO trial
- (2021) Carolina Porras et al. VACCINE
- Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
- (2020) Mojgan Karimi-Zarchi et al. BMC PUBLIC HEALTH
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Durability of Cross-Protection by Different Schedules of the Bivalent HPV Vaccine: the CVT Trial
- (2020) Sabrina H Tsang et al. JNCI-Journal of the National Cancer Institute
- Evaluation of durability of a single-dose of the bivalent HPV vaccine: the CVT Trial
- (2020) Aimée R Kreimer et al. JNCI-Journal of the National Cancer Institute
- The Use of Both Therapeutic and Prophylactic Vaccines in the Therapy of Papillomavirus Disease
- (2020) Anna Rosa Garbuglia et al. Frontiers in Immunology
- Peak neutralizing and cross-neutralizing antibody levels to human papillomavirus types 6/16/18/31/33/45/52/58 induced by bivalent and quadrivalent HPV vaccines
- (2020) Filipe Colaço Mariz et al. npj Vaccines
- HPV vaccination and cancer prevention
- (2020) A. Athanasiou et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Prophylactic human papillomavirus vaccination to prevent recurrence of cervical intraepithelial neoplasia: a meta-analysis
- (2020) Helena C Bartels et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Adjuvant Human Papillomavirus Vaccine to Reduce Recurrent Cervical Dysplasia in Unvaccinated Women
- (2020) Katie Lichter et al. OBSTETRICS AND GYNECOLOGY
- HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions
- (2020) Marta del Pino et al. Vaccines
- The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
- (2020) Jieliang Wang et al. AAPS PHARMSCITECH
- Prophylactic HPV vaccination after conization: A systematic review and meta-analysis
- (2020) M. Jentschke et al. VACCINE
- Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey
- (2020) Kalyani Sonawane et al. Lancet Public Health
- Efficacy of AS04-Adjuvanted Vaccine Against Human Papillomavirus (HPV) Types 16 and 18 in Clearing Incident HPV Infections: Pooled Analysis of Data From the Costa Rica Vaccine Trial and the PATRICIA Study
- (2020) Joseph E Tota et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial
- (2020) Carolina Porras et al. LANCET ONCOLOGY
- Assessing the Long-Term Role of Vaccination against HPV after Loop Electrosurgical Excision Procedure (LEEP): A Propensity-Score Matched Comparison
- (2020) Giorgio Bogani et al. Vaccines
- Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology
- (2019) Wui-Jin Koh et al. Journal of the National Comprehensive Cancer Network
- HPV Vaccine: Updates and Highlights
- (2019) Cristina Mendes de Oliveira et al. ACTA CYTOLOGICA
- Recurrent disease after treatment for cervical pre-cancer: determining whether prophylactic HPV vaccination could play a role in prevention of secondary lesions
- (2019) L. S. Velentzis et al. CLIMACTERIC
- Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo population
- (2019) Anna R. Giuliano et al. GYNECOLOGIC ONCOLOGY
- A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years
- (2019) Tino F. Schwarz et al. Human Vaccines & Immunotherapeutics
- Human papillomavirus and cervical cancer
- (2019) Kehinde Sharafadeen Okunade JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Risk of cervical intraepithelial neoplasia grade 2 or worse after conization in relation to HPV vaccination status
- (2019) Freja L. Sand et al. INTERNATIONAL JOURNAL OF CANCER
- Safety of the 9-Valent Human Papillomavirus Vaccine
- (2019) Tom T. Shimabukuro et al. PEDIATRICS
- Human papillomavirus vaccine against cervical cancer: Opportunity and challenge
- (2019) Renjie Wang et al. CANCER LETTERS
- Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis
- (2019) Marc Arbyn et al. Lancet Global Health
- ESGO Survey on Current Practice in the Management of Cervical Cancer
- (2018) Lukas Dostalek et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and 4vHPV vaccine administered according to two- or three-dose schedules in girls aged 9–14 years: Results to month 36 from a randomized trial
- (2018) Ting Fan Leung et al. VACCINE
- Explanations for the high potency of HPV prophylactic vaccines
- (2018) John Schiller et al. VACCINE
- Evidence for single-dose protection by the bivalent HPV vaccine—Review of the Costa Rica HPV vaccine trial and future research studies
- (2018) Aimée R. Kreimer et al. VACCINE
- SPERANZA project: HPV vaccination after treatment for CIN2+
- (2018) Alessandro Ghelardi et al. GYNECOLOGIC ONCOLOGY
- Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials
- (2018) M. Arbyn et al. Expert Review of Vaccines
- Long-Lasting Increased Risk of Human Papillomavirus–Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study
- (2017) Renée M.F. Ebisch et al. JOURNAL OF CLINICAL ONCOLOGY
- Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16–26 years: a randomised, double-blind trial
- (2017) Warner K Huh et al. LANCET
- Direct HPV E6/Myc interactions induce histone modifications, Pol II phosphorylation, and hTERT promoter activation
- (2017) Yiyu Zhang et al. Oncotarget
- Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection
- (2017) Maria Zurek Munk-Madsen et al. Human Vaccines & Immunotherapeutics
- Ten-year immune persistence and safety of the HPV-16/18 AS04-adjuvanted vaccine in females vaccinated at 15-55 years of age
- (2017) Tino F. Schwarz et al. Cancer Medicine
- Safety of Human Papillomavirus 9-Valent Vaccine: A Meta-Analysis of Randomized Trials
- (2017) Ana Paula Ferreira Costa et al. Journal of Immunology Research
- Impact of human papillomavirus (HPV) 16 and 18 vaccination on prevalent infections and rates of cervical lesions after excisional treatment
- (2016) Allan Hildesheim et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Experiences and lessons learned from 29 HPV vaccination programs implemented in 19 low and middle-income countries, 2009-2014
- (2016) Joël Ladner et al. BMC HEALTH SERVICES RESEARCH
- Prior human papillomavirus-16/18 AS04-adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy:Post-hocanalysis from a randomized controlled trial
- (2016) Suzanne M. Garland et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity and HPV infection after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre prospective cohort study
- (2016) Rengaswamy Sankaranarayanan et al. LANCET ONCOLOGY
- Antitumor dendritic cell–based vaccines: lessons from 20 years of clinical trials and future perspectives
- (2016) João Constantino et al. Translational Research
- Less than 3 doses of the HPV vaccine – Review of efficacy against virological and disease end points
- (2016) Partha Basu et al. Human Vaccines & Immunotherapeutics
- Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
- (2016) Julianne Gee et al. Human Vaccines & Immunotherapeutics
- Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices
- (2016) Elissa Meites et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects
- (2016) Erin M. Scherer et al. EBioMedicine
- From the monovalent to the nine-valent HPV vaccine
- (2015) S. Pils et al. CLINICAL MICROBIOLOGY AND INFECTION
- Development of a highly thermostable, adjuvanted human papillomavirus vaccine
- (2015) Kimberly J. Hassett et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Effect of vaccine administration modality on immunogenicity and efficacy
- (2015) Lu Zhang et al. Expert Review of Vaccines
- Cancer of the cervix: Early detection and cost-effective solutions
- (2015) Lynette Denny et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis
- (2015) Robine Donken et al. JOURNAL OF INFECTION
- Influence of a loop electrosurgical excision procedure (LEEP) on levels of cytokines in cervical secretions
- (2015) Audrey F. Saftlas et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9–15-Year-Old Girls
- (2015) Timo Vesikari et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Safety and immunogenicity of a 9-valent HPV vaccine in females 12–26 years of age who previously received the quadrivalent HPV vaccine
- (2015) Suzanne M. Garland et al. VACCINE
- Reduced dose human papillomavirus vaccination: An update of the current state-of-the-art
- (2015) Zheng Quan Toh et al. VACCINE
- Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease
- (2015) David Radley et al. Human Vaccines & Immunotherapeutics
- HPV vaccines: Translating immunogenicity into efficacy
- (2015) Taylor B. Turner et al. Human Vaccines & Immunotherapeutics
- Role of Cytokines in Genesis, Progression and Prognosis of Cervical Cancer
- (2014) Prajakta Hemant Paradkar et al. Asian Pacific Journal of Cancer Prevention
- Safety, tolerability and side effects of human papillomavirus vaccines: a systematic quantitative review
- (2014) Ana Katherine Gonçalves et al. Brazilian Journal of Infectious Diseases
- Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types
- (2014) K Kavanagh et al. BRITISH JOURNAL OF CANCER
- Human papillomavirus vaccines: key factors in planning cost-effective vaccination programs
- (2014) Sandra D Isidean et al. Expert Review of Vaccines
- Effect of ageing on cervical or vaginal cancer in Swedish women previously treated for cervical intraepithelial neoplasia grade 3: population based cohort study of long term incidence and mortality
- (2014) B. Strander et al. BMJ-British Medical Journal
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- (2014) E. Crowe et al. BMJ-British Medical Journal
- Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
- (2013) Dorota M Gertig et al. BMC Medicine
- Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
- (2013) M. Safaeian et al. Cancer Prevention Research
- HPV vaccine cross-protection: Highlights on additional clinical benefit
- (2013) Rosa De Vincenzo et al. GYNECOLOGIC ONCOLOGY
- Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade cervical intraepithelial neoplasia (CIN2–3)?
- (2013) Woo Dae Kang et al. GYNECOLOGIC ONCOLOGY
- Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort study
- (2013) Mark E. Scott et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Human papillomavirus and cervical cancer
- (2013) Emma J Crosbie et al. LANCET
- HPV vaccine acceptability among men: a systematic review and meta-analysis
- (2013) Peter A Newman et al. SEXUALLY TRANSMITTED INFECTIONS
- The E1 proteins
- (2013) Monika Bergvall et al. VIROLOGY
- Prevention of Recurrent High-Grade Anal Neoplasia With Quadrivalent Human Papillomavirus Vaccination of Men Who Have Sex With Men: A Nonconcurrent Cohort Study
- (2012) K. A. Swedish et al. CLINICAL INFECTIOUS DISEASES
- Predictors of absence of cervical intraepithelial neoplasia in the conization specimen
- (2012) Agata Rodriguez-Manfredi et al. GYNECOLOGIC ONCOLOGY
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study
- (2012) M. Rebolj et al. BMJ-British Medical Journal
- Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18
- (2011) A. Szarewski et al. INTERNATIONAL JOURNAL OF CANCER
- Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study
- (2011) Mariëlle Kocken et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human Papillomavirus Vaccination Series Initiation and Completion, 2008-2009
- (2011) C. G. Dorell et al. PEDIATRICS
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- HPV vaccine: Cervarix
- (2010) Anne Szarewski EXPERT OPINION ON BIOLOGICAL THERAPY
- Potential mechanisms for HPV vaccine-induced long-term protection
- (2010) Margaret Stanley GYNECOLOGIC ONCOLOGY
- Currently approved prophylactic HPV vaccines
- (2009) Diane M Harper Expert Review of Vaccines
- The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Sexually Active Women Aged 16–26 Years
- (2009) Cosette M. Wheeler et al. JOURNAL OF INFECTIOUS DISEASES
- Interferon-γ (IFN-γ): A possible prognostic marker for clearance of high-risk human papillomavirus (HPV)
- (2008) Seung-Hun Song et al. GYNECOLOGIC ONCOLOGY
- Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
- (2008) Paul Henri Lambert et al. VACCINE
- Interaction of human papillomaviruses with the host immune system: A well evolved relationship
- (2008) Ian H. Frazer VIROLOGY
- Papillomavirus E6 proteins
- (2008) Heather L. Howie et al. VIROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started